Karmic Lifesciences

Mumbai, India Founded: 2005 • Age: 21 yrs Acquired By Cliantha
CRO offering clinical management services

About Karmic Lifesciences

Karmic Lifesciences is a company based in Mumbai (India) founded in 2005 was acquired by Cliantha in July 2014.. Karmic Lifesciences has raised $2 million across 2 funding rounds from investors including Mumbai Angels, Cliantha and Basil Partners. The company has 163 employees as of October 31, 2024. Karmic Lifesciences operates in a competitive market with competitors including Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.

  • Headquarter Mumbai, India
  • Employees 163 as on 31 Oct, 2024
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $75.08 M (USD)
    9
    as on Mar 31, 2024
  • Net Profit
    $9.28 M (USD)
    -16
    as on Mar 31, 2024
  • EBITDA
    $16.08 M (USD)
    -6
    as on Mar 31, 2024
  • Total Equity Funding
    $2 M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.5 M (USD), Series A

    May 28, 2010

  • Investors
  • Employee Count
    163

    as on Oct 31, 2024

  • Acquired by
    Cliantha

    (Jul 30, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Karmic Lifesciences

Karmic Lifesciences has successfully raised a total of $2M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.5 million completed in May 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $1.5M
  • First Round

    (03 May 2009)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2010 Amount Series A - Karmic Lifesciences Valuation

investors

May, 2009 Amount Seed - Karmic Lifesciences Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Karmic Lifesciences

Karmic Lifesciences has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Mumbai Angels, Cliantha and Basil Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage venture investments are facilitated by Mumbai Angels network.
Founded Year Domain Location
Tech and Life Sciences focused VC firm investing in the US and India
Founded Year Domain Location
Angel investor network investing in early-stage startups
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Karmic Lifesciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Karmic Lifesciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Karmic Lifesciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Karmic Lifesciences

Karmic Lifesciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Outsourced contract research organization services are provided to clients.
domain founded_year HQ Location
CRO clinical development services are provided by Syneos Health.
domain founded_year HQ Location
Clinical trials and regulatory submissions are supported as a CRO.
domain founded_year HQ Location
CRO focused on data management, regulatory affairs and consulting services
domain founded_year HQ Location
Full-service CRO expertise in influenza and oncology research is offered.
domain founded_year HQ Location
Therapies for cancer and inflammatory diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Karmic Lifesciences

Frequently Asked Questions about Karmic Lifesciences

When was Karmic Lifesciences founded?

Karmic Lifesciences was founded in 2005 and raised its 1st funding round 4 years after it was founded.

Where is Karmic Lifesciences located?

Karmic Lifesciences is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Is Karmic Lifesciences a funded company?

Karmic Lifesciences is a funded company, having raised a total of $2M across 2 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on May 03, 2009.

How many employees does Karmic Lifesciences have?

As of Oct 31, 2024, the latest employee count at Karmic Lifesciences is 163.

What is the annual revenue of Karmic Lifesciences?

Annual revenue of Karmic Lifesciences is $75.08M as on Mar 31, 2024.

What does Karmic Lifesciences do?

Karmic Lifesciences is a full-service contract research organization headquartered in India with global execution capabilities in the US, Europe and APAC. It provides clinical trials and clinical data management bio-statistics projects (Phase I to IV) in various therapeutic areas including Oncology, Cardiovascular, Diabetes, Neurology, Auto-Immune Diseases, Ophthalmology, and Medical Devices. It also launched medico-marketing services for the pharmaceutical industry. Also, developed kTrials, a web-enabled eClinical suite with integrated clinical trial management, clinical data management, clinical data warehousing and operational analytics functionalities. It was funded by India Angels Network, Mumbai Angels, Basil Growth, Blume Ventures. It was acquired by Cliantha Research in July 2014.

Who are the top competitors of Karmic Lifesciences?

Karmic Lifesciences's top competitors include Emmes, Syneos Health and ClinChoice.

Who are Karmic Lifesciences's investors?

Karmic Lifesciences has 4 investors. Key investors include Mumbai Angels, Cliantha, Basil Partners, and Indian Angel Network.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available